This announcement is a separate document:
基石藥業-B：自願公告 - 首席執行官兼執行董事楊建新博士新增持公司46萬股股份，累計增持373.25萬股
CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - FURTHER INCREASE IN SHAREHOLDING BY CEO AND EXECUTIVE DIRECTOR DR. JIANXIN YANG BY 460,000 SHARES, WITH ACCUMULATED PURCHASE TOTALLING 3,732,500 SHARES
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.